전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,399 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleThe Netherlands Cancer InstitutePhase 3

nivolumab (Opdivo, Adjuvant nivolumab)

Malignant Melanoma Stage III · Malignant Melanoma Stage III

#MalignantMelanomaStageIII#Antibody#Phase3#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

Administration of rituximab and methylprednisolone (Administration of rituximab and methylprednisolone)

Early and Severe Systemic Sclerosis · Early and Severe Systemic Sclerosis

#EarlyandSevereSystemicSclerosis#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

trastuzumab (Herceptin, Ado-trastuzumab emtamsine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#monoclonal-antibody#Roche
Trials 1Status Recruiting
CGTLimited DatastaleCytoMed Therapeutics Pte LtdPhase 1

Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell (Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell)

Colorectal Cancer; Triple Negative Breast Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleAbbViePhase 3

Adalimumab (Advixa, Advixa (Adalimumab))

Pharmacokinetics; Safety · Pharmacokinetics

#Pharmacokinetics#Antibody#Phase3#monoclonal-antibody#Safety+1
Trials 1Status Active
AntibodyLimited DatastaleChinese Medical AssociationApproved

Akkermansia muciniphila + Infliximab (Akkermansia muciniphila + Infliximab)

Crohn's Diseases · Crohn's Diseases

#CrohnsDiseases#Antibody#Approved#monoclonal-antibody#Chinese
Trials 1Status Recruiting
CGTLimited DatastaleMayo ClinicPhase 1

Alefacept (Alefacept)

Lymphoma · Lymphoma

#Lymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
AntibodyLimited DatastaleGoethe UniversityPhase 2

MabCampath (Alemtuzumab, Alemtuzumab (MabCampath))

Adult Acute Lymphocytic Leukemia T-cell; Lymphoma, Lymphoblastic · Adult Acute Lymphocytic Leukemia T-cell

#AdultAcuteLymphocyticLeukemiaT-c#Antibody#Phase2#monoclonal-antibody#Lymphoma+2
Trials 1Status Active
AntibodyLimited DatastaleGerman CLL Study GroupPhase 2

Alemtuzumab i.v. (Alemtuzumab i.v.)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#German
Trials 1Status Active
AntibodyLimited DatastaleGerman CLL Study GroupPhase 2

Alemtuzumab s.c. (Alemtuzumab s.c.)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#German
Trials 1Status Active
CGTLimited DatastaleAvenCell Therapeutics, Inc.Phase 2

Allo-QuadCAR01-T (Allo-QuadCAR01-T)

Lymphoma Diffuse Large B-cell; Leukemia and Lymphoma · Lymphoma Diffuse Large B-cell

#LymphomaDiffuseLargeB-cell#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleAvenCell Europe GmbHPhase 1

Allo-RevCAR01-T (Allo-RevCAR01-T)

Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleInstituto de Investigación Hosp…Phase 1

Allogeneic CART-NKG2D cells (Allogeneic CART-NKG2D cells)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · Precursor Cell Lymphoblastic Leukemia-Ly

#PrecursorCellLymphoblasticLeukem#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleMustang Bio, Inc.Phase 1

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

Allogeneic CD5.CAR/28zeta CAR T cells (Allogeneic CD5.CAR/28zeta CAR T cells)

T-cell Acute Lymphoblastic Lymphoma; T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Lymphoma

#T-cellAcuteLymphoblasticLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleIRCCS Azienda Ospedaliero-Unive…Preclinical

Alloreactive NK cell infusion (Alloreactive NK cell infusion)

Adult Acute Myeloid Leukemia in Remission · Adult Acute Myeloid Leukemia in Remissio

#AdultAcuteMyeloidLeukemiainRemis#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Active
AntibodyLimited DatastaleKymab LimitedPhase 2

Alomfilimab (Alomfilimab)

Squamous Cell Carcinoma of Head and Neck; Non-small Cell Lung Cancer · Squamous Cell Carcinoma of Head and Neck

#SquamousCellCarcinomaofHeadandNe#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancer+1
Trials 1Status Discontinued
AntibodyLimited DatastaleShanghai Celfuture Biotech Co.,…Phase 2

Ametumumab (Ametumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Shanghai
Trials 1Status Active
AntibodyLimited DatastaleJanssenPhase 2

Amivantamab and Recombinant Human Hyaluronidase (Amivantamab and Recombinant Human Hyaluronidase)

Locally Recurrent Skin Squamous Cell Carcinoma; Metastatic Skin Squamous Cell Carcinoma · Locally Recurrent Skin Squamous Cell Car

#LocallyRecurrentSkinSquamousCell#Antibody#Phase2#monoclonal-antibody#MetastaticSkinSquamousCellCarcin+1
Trials 1Status Discontinued
CGTLimited DatastaleHyungwoo ChoPhase 2

Anbal-cel (Anbal-cel)

Primary CNS Lymphoma (PCNSL); Diffuse Large B Cell Lymphoma (DLBCL) · Primary CNS Lymphoma (PCNSL)

#PrimaryCNSLymphomaPCNSL#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting

47 / 120 pages

← PreviousNext →